Inventor
MCGARRY DANIEL G
US16 patents
⚠️ This page may combine multiple inventors who share the name “MCGARRY DANIEL G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVENTIS PHARMA INC
6 patentsUS7326792B2Feb 5, 2008
Heterocyclic compounds as P2X7 ion channel blockers
AVENTIS PHARMA INC29 citations89
US7741493B2Jun 22, 2010
Heterocyclic compounds as P2X7 ion channel blockers
AVENTIS PHARMA INC8 citations81
US6541505B1Apr 1, 2003
Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds
AVENTIS PHARMA INC7 citations72
US7638539B2Dec 29, 2009
1, 3, 4-oxadiazol-2-ones as peroxisome-proliferator activated receptor delta modulators and their use in the treatment of neurological and metabolic disease
AVENTIS PHARMA INC2 citations61
US6599918B2Jul 29, 2003
Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
AVENTIS PHARMA INC3 citations61
US7576109B2Aug 18, 2009
1,3,4-oxadiazol-2-ones as PPAR delta modulators and their use thereof
AVENTIS PHARMA INC0 citations40
RHONE POULENC RORER PHARMA
4 patentsUS6034093AMar 7, 2000
Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
RHONE POULENC RORER PHARMA28 citations92
US5571506ANov 5, 1996
Aromatic oligomeric compounds useful as mimics of bioactive macromolecules
RHONE POULENC RORER PHARMA47 citations91
US5731315AMar 24, 1998
Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds
RHONE POULENC RORER PHARMA20 citations83
US5216015AJun 1, 1993
Compounds having hypocholesterolemic properties
RHONE POULENC RORER PHARMA12 citations73